Randomised,  controlled intervention study

VIA, cervical cytology, HPV testing

Osmanabad district, India

160,000 women 30-59 years

Cervical cancer incidence/ mortality; Cost-effectiveness; establishment of a service and training platform for cervical cancer prevention.

Randomised, controlled intervention study

VIA

Dindigul District, India

73,000 women aged 30-59 years

Detection rates of CIN2-3Cervical cancer incidence/mortality; Cost-effectiveness; establishment of a service and training platform for cervical cancer prevention.

Cross-sectional study

VIA, VILI

Burkina Faso, Republic of Congo, Guinea,  Hyderabad, India, Laos, Mali, Niger, Mauritania, Tanzania

5000 women aged 30-59 in each location

Test characteristics; Acceptability, efficacy, complications of cryotherapy; establishment of a service and training platform for cervical cancer prevention.

Cross-sectional study

VIA, cytology

Nigeria

2000 women aged 30-64 years

Test characteristics; Acceptability, efficacy, complications of cryotherapy; establishment of a service and training platform for cervical cancer prevention.

Cross-sectional study

VIA, VILI, cervical cytology

Trivandrum and Jaipur India

6000 women 30-59 years in each location

Test characteristics; Acceptability, efficacy, complications of cryotherapy; establishment of a service and training platform for cervical cancer prevention.

Cross-sectional study

VIA, VIAM, VILI, cervical cytology, HPV testing

Calcutta, India

12,000 women aged 30-64 years

Test characteristics; Acceptability, efficacy, complications of cryotherapy; establishment of a service and training platform for cervical cancer prevention.

Cross sectional study

Cervical cytology, HPV testing, VIA, VIAM, VILI

Bombay, India

5000 women aged 30-59 years

Test characteristics; Acceptability, efficacy, complications of cryotherapy; establishment of a service and training platform for cervical cancer prevention.